X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Indoco Remedies with Compact Disc - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

INDOCO REMEDIES vs COMPACT DISC - Comparison Results

INDOCO REMEDIES    Change

Indoco Remedies is engaged in the manufacturing and marketing of formulations and active pharmaceutical ingredients (APIs) for domestic as well as the international markets. The company's focus areas include anti-infective, respiratory, anti-diabetic... More

COMPACT DISC 
   Change

Compact Disc Indai (CDI) is India's leading integrated media and entertainment company and South Asia's largest animation company with prime focus on animation outsourcing and production. Incorporated in 1992, its product range covers all the segment... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    INDOCO REMEDIES COMPACT DISC INDOCO REMEDIES/
COMPACT DISC
 
P/E (TTM) x 43.8 -7.8 - View Chart
P/BV x 2.8 0.0 14,549.4% View Chart
Dividend Yield % 0.8 0.0 -  

Financials

 INDOCO REMEDIES   COMPACT DISC
EQUITY SHARE DATA
    INDOCO REMEDIES
Mar-17
COMPACT DISC
Mar-13
INDOCO REMEDIES/
COMPACT DISC
5-Yr Chart
Click to enlarge
High Rs36031 1,162.6%   
Low Rs2499 2,896.5%   
Sales per share (Unadj.) Rs119.00-  
Earnings per share (Unadj.) Rs8.4-0.3 -2,882.0%  
Cash flow per share (Unadj.) Rs15.2-0.2 -6,264.2%  
Dividends per share (Unadj.) Rs1.600-  
Dividend yield (eoy) %0.50-  
Book value per share (Unadj.) Rs70.789.7 78.8%  
Shares outstanding (eoy) m92.1512.75 722.7%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x2.6NM-  
Avg P/E ratio x36.4-68.2 -53.4%  
P/CF ratio (eoy) x20.0-81.4 -24.6%  
Price / Book Value ratio x4.30.2 1,953.7%  
Dividend payout %19.10-   
Avg Mkt Cap Rs m28,083252 11,124.1%   
No. of employees `0006.0NA-   
Total wages/salary Rs m2,1671 361,116.7%   
Avg. sales/employee Rs Th1,817.0NM-  
Avg. wages/employee Rs Th359.0NM-  
Avg. net profit/employee Rs Th127.7NM-  
INCOME DATA
Net Sales Rs m10,9680-  
Other income Rs m400-   
Total revenues Rs m11,0070-   
Gross profit Rs m1,565-3 -52,153.3%  
Depreciation Rs m6331 105,466.7%   
Interest Rs m620-   
Profit before tax Rs m909-4 -25,261.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1390 138,700.0%   
Profit after tax Rs m771-4 -20,829.7%  
Gross profit margin %14.3NM- 
Effective tax rate %15.3-2.8 -549.1%   
Net profit margin %7.0NM- 
BALANCE SHEET DATA
Current assets Rs m5,725627 913.6%   
Current liabilities Rs m5,454157 3,476.2%   
Net working cap to sales %2.5NM- 
Current ratio x1.04.0 26.3%  
Inventory Days Days62NM- 
Debtors Days Days72NM- 
Net fixed assets Rs m5,30725 21,144.9%   
Share capital Rs m184127 144.9%   
"Free" reserves Rs m6,3311,017 622.5%   
Net worth Rs m6,5161,144 569.4%   
Long term debt Rs m1,323178 745.4%   
Total assets Rs m11,9701,480 809.0%  
Interest coverage x15.6NM-  
Debt to equity ratio x0.20.2 130.9%  
Sales to assets ratio x0.90-   
Return on assets %7.0-0.3 -2,782.3%  
Return on equity %11.8-0.3 -3,658.3%  
Return on capital %12.4-0.3 -4,550.6%  
Exports to sales %0NM-  
Imports to sales %0NM-  
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m4,5070-   
Fx outflow Rs m1,1410-   
Net fx Rs m3,3660-   
CASH FLOW
From Operations Rs m8860 295,466.7%  
From Investments Rs m-1,706-1 284,250.0%  
From Financial Activity Rs m1,316NA-  
Net Cashflow Rs m4970 -165,533.3%  

Share Holding

Indian Promoters % 59.2 22.6 261.9%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 12.5 0.0 -  
FIIs % 6.0 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 22.4 77.4 28.9%  
Shareholders   12,805 28,898 44.3%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare INDOCO REMEDIES With:   CCL INTERNATIONAL  ADANI PORTS & SEZ  COX & KINGS  MOTILAL OSWAL  THOMAS COOK INDIA  



Today's Market

Sensex Ends 207 Points Higher; Healthcare Stocks Witness Buying(Closing)

Indian share markets continued to trade in the green during the closing hours of the trading session and ended the day on a positive note.

Related Views on News

INDOCO REMEDIES Announces Quarterly Results (4QFY18); Net Profit Up 14.3% (Quarterly Result Update)

Jun 19, 2018 | Updated on Jun 19, 2018

For the quarter ended March 2018, INDOCO REMEDIES has posted a net profit of Rs 205 m (up 14.3% YoY). Sales on the other hand came in at Rs 3 bn (down 2.6% YoY). Read on for a complete analysis of INDOCO REMEDIES's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

More Views on News

Most Popular

How to Make Big Profits by Following India's Best Investors(The 5 Minute Wrapup)

Aug 3, 2018

In a time when stocks recommended by so-called 'gurus of the market' are crashing, let Kunal Thanvi guide you to the best gurus...and their best stocks.

The Biggest Mistake You Can Make in this Market (and 3 Stocks to Buy Now!)(Profit Hunter)

Aug 3, 2018

This price pattern can help you identify stocks on the verge of a turnaround.

Does This Indicator Tell Us the Sensex is Headed for a Correction?(Vivek Kaul's Diary)

Aug 3, 2018

To what extent have foreign flows influenced Indian stock markets? How do we see it panning out now?

Is Franklin India Smaller Companies Fund Worth Your Money(Outside View)

Aug 2, 2018

Although positioned as a small cap fund, Franklin India Smaller Companies Fund has been investing a significant portion of its assets in mid-caps along with a nominal exposure to large caps.

Why HDFC Equity Fund Disappointed Its Investors(Outside View)

Aug 9, 2018

Though popular, HDFC Equity Fund is not among the best performers anymore. Here is the reason behind its underperformance that has left investors disappointed.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

INDOCO REMEDIES SHARE PRICE


Aug 14, 2018 (Close)

TRACK INDOCO REMEDIES

  • Track your investment in INDOCO REMEDIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON INDOCO REMEDIES

INDOCO REMEDIES 8-QTR ANALYSIS

COMPARE INDOCO REMEDIES WITH

MARKET STATS